Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
Howard, Frederick
Predicting response of molecular targeted therapies: a still possible challenge?
Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study.
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors.
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors. J Thorac Oncol. 2020 03; 15(3):360-370.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
Mutation
authors with profiles
Marina Chiara Garassino